Reply from the authors

Neurology

Volumn 74, Issue 24, 2010, Pages 2026-2027

  Salloway, S P ^a   Black, R ^a   Sperling, R ^a   Fox, N ^a   Gilman, S ^a   Schenk, D ^a   Grundman, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; BAPINEUZUMAB; IMMUNOMODULATING AGENT;

ALZHEIMER DISEASE; BLOOD VESSEL PERMEABILITY; BRAIN EDEMA; FLUID SHIFT; GENOTYPE; HUMAN; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; VASCULAR AMYLOIDOSIS;

EID: 77953781764     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181e03844     Document Type: Letter

References (9)

1. Salloway S, Sperling R, Gilman S, et al. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 2009;73:2061-2070.
2. Laskowitz DT, Vitek MP. Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions. Pharmacogenomics 2007;8:959-969.
3. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci 1993;90: 8098-8102.
4. Laskowitz DT, Thekdi AD, Thekdi SD, et al. Downregu-lation of microglial activation by apolipoprotein E and apoE-mimetic peptides. Exp Neurol 2001;167:74-85.
5. Szekely CA, Breitner JC, Fitzpatrick AL, et al. NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type. Neurology 2002;70:17-24.
6. Oh U, Gupta R, Krakauer JW, Khandji AG, Chin SS, Elkind MS. Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. Neurology 2004;62:494-497.
7. Chalmers K, Wilcock GK, Love S. APOE4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Neuropathol Appl Neurobiol 2003;29:231-238.
8. Kinnecom C, Lev MH, Wendell L, et al. Course of cerebral amyloid angiopathy-related inflammation. Neurology 2007;68:1411-1416.
9. Boche D, Zotova E, Weller RO, et al. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. Brain 2008;131:3299-3310.